ID
11715
Beschreibung
This study will compare the effect of a prasugrel 10-mg maintenance dose with a clopidogrel 75-mg maintenance dose on platelet activity, approximately 1 week after the first dose of study drug, in subjects who have been taking clopidogrel 75 mg daily following a percutaneous coronary intervention (PCI) with placement of a stent, performed to treat acute coronary syndrome (ACS). https://clinicaltrials.gov/ct2/show/NCT00356135
Link
https://clinicaltrials.gov/ct2/show/NCT00356135
Stichworte
Versionen (1)
- 28.07.15 28.07.15 -
Hochgeladen am
28. Juli 2015
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility SWAP Acute Coronary Syndrome NCT00356135
Eligibility Criteria
- StudyEvent: ODM
Beschreibung
Exclusion Criteria
Beschreibung
Left main coronary artery stent
Datentyp
boolean
Alias
- UMLS CUI-1
- N
Beschreibung
left anterior descending (LAD) bifurcation stent
Datentyp
boolean
Alias
- UMLS CUI-1
- C3836455
Beschreibung
Have any form of coronary revascularization (percutaneous coronary intervention [PCI] or coronary artery bypass grafting [CABG]) planned to occur during the study (from signing consent through the final visit).
Datentyp
boolean
Alias
- UMLS CUI-1
- C1532338
Beschreibung
Have any form of coronary revascularization (percutaneous coronary intervention [PCI] or coronary artery bypass grafting [CABG]) planned to occur during the study (from signing consent through the final visit).
Datentyp
boolean
Alias
- UMLS CUI-1
- C0010055
Beschreibung
Receiving or will receive oral anticoagulation (other than aspirin and clopidogrel) that cannot be safely discontinued for the duration of the study.
Datentyp
boolean
Alias
- UMLS CUI-1
- C0354604
Beschreibung
Receiving or will receive other antiplatelet therapy (other than aspirin and clopidogrel) that cannot be safely discontinued for the duration of the study.
Datentyp
boolean
Alias
- UMLS CUI-1
- C1096021
Beschreibung
Receiving daily treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) that cannot be discontinued or are anticipated to require daily treatment with NSAIDs during the study.
Datentyp
boolean
Alias
- UMLS CUI-1
- C0003211
Beschreibung
history of ischemic or hemorrhagic stroke
Datentyp
boolean
Alias
- UMLS CUI-1
- C0559159
Beschreibung
Intracranial neoplasm
Datentyp
boolean
Alias
- UMLS CUI-1
- C1527390
Beschreibung
Arteriovenous malformation
Datentyp
boolean
Alias
- UMLS CUI-1
- C0003857
Beschreibung
Aneurysm
Datentyp
boolean
Alias
- UMLS CUI-1
- C0002940
Beschreibung
History of transient ischemic attack (TIA)
Datentyp
boolean
Alias
- UMLS CUI-1
- C0455536
Beschreibung
Have a body weight less than 60 kilograms (kg)
Datentyp
boolean
Ähnliche Modelle
Eligibility Criteria
- StudyEvent: ODM